NOBLE - TCAD Study

Investigator: Joseph Masdeu, MD

Study Coordinator: Jennifer Garrett

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT02079909

Phone: 713.441.9484

IRB Number: Pro00010841

Description

The primary objective is to evaluate the efficacy of T-817MA as measured by ADAS-cog and ADCS-CGIC. The secondary objectives are: To evaluate the safety and tolerability of T-817MA measured by clinical safety laboratories, physical examinations, ECGs and solicitation of adverse events. To evaluate the efficacy of T-817MA as measured by ADCS-ADL, FAQ, Neuropsychiatric Inventory (NPI) and Mini-mental State Examination (MMSE).
More to Explore